Page last updated: 2024-10-28

beta-thujaplicin and Cancer of Cervix

beta-thujaplicin has been researched along with Cancer of Cervix in 1 studies

beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wang, CC1
Chen, BK1
Chen, PH1
Chen, LC1

Other Studies

1 other study available for beta-thujaplicin and Cancer of Cervix

ArticleYear
Hinokitiol induces cell death and inhibits epidermal growth factor-induced cell migration and signaling pathways in human cervical adenocarcinoma.
    Taiwanese journal of obstetrics & gynecology, 2020, Volume: 59, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Movement; Epidermal Growth Factor

2020